Navigation Links
Nanomedicines promise fewer side effects in treating cancer
Date:6/7/2012

A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News (C&EN). C&EN is the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.

In the cover story, C&EN Senior Editor Bethany Halford explains that today's anti-cancer medications impact healthy tissue in the process of killing cancer cells. Patients thus may experience side effects, such as nausea and vomiting, that in some instances can be so severe that patients decline further treatment. New nanomedicine cancer treatments promise to focus on diseased tissue while leaving healthy parts of the body unscathed, reducing the severity of side effects.

The article explains how a new generation of nanoparticle-based medications bring anti-cancer drugs directly to the tumor. Because of their ultra-small size, particles of these drugs can slip through tiny passages in the blood vessels that nourish tumors, get inside tumors and even individual cancer cells, and do their work with precision. The article describes nanomedicines that already are in clinical trials with cancer patients and others that are moving in that direction.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
2. Antioxidant shows promise as treatment for certain features of autism, Stanford study finds
3. New TB test promises to be cheap and fast
4. In Rat Study, Eye Device Shows Promise for Restoring Sight
5. New Weight-Loss Drug Shows Promise in Trial
6. New Drug Shows Promise for Myeloma Patients
7. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
8. New Method to Reveal Alzheimers Marker Shows Promise
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Mechanical tissue resuscitation technology shows promise
11. Experimental Pill for Multiple Sclerosis Shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... ... 12, 2017 , ... Vohra Chief Medical Officer Dr. Shark ... skilled nursing facility medical directors and other clinicians at various events in October. ... "At many of these conferences we get to educate other physicians, facility nurses, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: